IRS — the NYSE-listed ADR for Argentine real estate conglomerate IRSA Inversiones y Representaciones — arrives at its May 6 earnings print with a striking split: options traders piling into calls while the stock sits near oversold levels after a rough week.
The options market tells the most bullish story of any data point this week. The put/call ratio has collapsed to 0.127 — close to its 52-week floor of 0.095 and well below its 20-day average of 0.212. That reading is 1.2 standard deviations below the mean, reflecting unusually heavy call demand relative to puts. The shift happened abruptly: the PCR ran above 0.30 throughout mid-April, then dropped sharply in the final week of the month. Traders appear to be positioning for a recovery or a positive earnings surprise, even as the stock itself has done the opposite.
The stock is down 6.4% this week to $14.17 — a bruising stretch that leaves it off 12% year-to-date. The 14-day RSI has slid to 36.65, edging toward oversold territory. That price weakness is arriving at an uncomfortable moment: the last four earnings events all ended with the ADR lower. Day-one post-earnings moves ranged from -1.5% to -5.4%, and five-day outcomes were consistently worse, ranging from -6% to -8%. The call positioning ahead of May 6 therefore represents either a view that the pattern breaks, or a short-term trade on an expected bounce into the announcement.
Short interest tells a much quieter story. Estimated shorts rose about 24% over the week to roughly 181,000 shares — but that amounts to a fraction of a percent of the free float of approximately 2.35 billion shares. Borrow costs have actually eased considerably, falling roughly 24% over the past month to 1.46% APR. Availability is loose. There is no meaningful short-seller pressure in the lending market here; the week's SI move reflects small absolute numbers, not a structural bearish build.
The institutional register contains the week's most substantive development. Helikon Investments added approximately 41.3 million shares, bringing its stake to 5.18% of the company — one of the largest holder position changes in the register. Brevan Howard built a position of roughly 3.96 million shares from near zero. Both changes were reported as of December 31, 2025, but they represent meaningful new institutional conviction in the ADR. Controlling shareholder Cresud holds 51.6% of shares and has not changed its position. Chairman and founder Eduardo Elsztain made two small sales in mid-March, totalling roughly $46,000 in value — low significance in absolute terms.
Valuation has re-rated downward sharply over the past month. The trailing P/E has contracted from above 70x to 53.7x, and the P/B has slipped to 8.2x. The EV/EBITDA of 59.9x remains elevated by most standards, though this is an Argentine real estate business with peso-denominated assets and USD-listed equity — currency dynamics and inflation accounting complicate direct comparisons. On the Street, the only available analyst reference (a Jefferies upgrade to Buy with a $13 target from August 2024) is too dated to be actionable. The analyst mean price target of $20.50, last updated in January 2026, implies substantial upside to the current price, but the absence of recent coverage changes limits its informational value.
The May 6 print is therefore the immediate focal point: whether the call-heavy positioning ahead of earnings can be validated by the result — or whether the stock repeats its post-print pattern of drifting lower in the days that follow.
See the live data behind this article on ORTEX.
Open IRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
